Accuray (NASDAQ: ARAY)
Accuray Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Accuray Company Info
Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
News & Analysis
Why Shares of Accuray Rose Thursday
The company released its fiscal 2023 third-quarter numbers after the bell Wednesday.
Why Shares of Accuray Jumped Thursday
The radiation-oncology machine company saw shares rise after it released an earnings report.
Why Accuray Shares Are Soaring Today
Investors liked the medical-device maker's better-than-expected Q2 results.
Here's How Accuray Hit a Home Run With Its Q2 Earnings Update
There was good news on multiple fronts for the medical device maker.
Better Buy: Intuitive Surgical vs. Accuray
Which stock is the better option for investors looking to profit from the market for medical devices?
Better Buy: Intuitive Surgical vs. Accuray
Which stock wins in a head-to-head battle between these two medical device makers?
High-Tech Robotic Surgery Gets Specialized
Accuray and Stereotaxis are hyper-focused on growth
Here's Why Accuray Stock Is Nosediving Today
Disappointing fourth-quarter results are taking a toll on the medical device stock.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.